NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Rosen Law Firm PAWHY: Rosen Law Firm, a global investor rights law firm, continues to ...

New York, New York-- (Newsfile Corp. - February 11, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...

Needham & Company LLC reissued their hold rating on shares of TransMedics Group (NASDAQ:TMDX – Free Report) in a research ...

CENTRAL TRUST Co lifted its stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 162.2% in the 4th quarter, ...

NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential violations ...

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential violations ...

Tuesday saw Canaccord Genuity reaffirm its Buy rating and $104.00 price target for TransMedics Group (NASDAQ:TMDX) shares, following the release of recent transplant data. The data, provided by the ...

In truth, it appears that TransMedics fueled its growth by engaging in an anti-competitive scheme, including providing kickbacks to medical providers. The company further boosted growth by engaging in ...

Buy TMDX near 57.46 target 99.64 stop loss @ 57.29 Details The technical summary data tells us to buy TMDX near 57.46 with an upside target of 99.64. This data also tells us to set a stop loss @ 57.29 ...

The recently rebranded Microsoft Office is still probably the most popular productivity suite worldwide despite many free ...